Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Oncogene|March 15, 2016
Hypoxia and MITF regulate KIT oncogenic properties in melanocytesF Laugier, J Delyon, J André, et al.
Cancer Treatment Reviews|October 16, 2021
Turning tumors from cold to inflamed to improve immunotherapy responseC L Gerard, J Delyon, A Wicky, et al.
Annales De Dermatologie Et De Venereologie|January 19, 2013
[Cutaneous manifestations revealing cryofibrinogenaemia associated with monoclonal gammopathy]J Delyon, M Bezier, F Cordoliani, et al.
Oncogene|January 17, 2017
PDE4D promotes FAK-mediated cell invasion in BRAF-mutated melanomaJ Delyon, A Servy, F Laugier, et al.
The British Journal of Dermatology|May 12, 2019
Acquired generalized lipodystrophy under immune checkpoint inhibitionN Haddad, T Vidal-Trecan, B Baroudjian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 27, 2013
Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survivalJ Delyon, C Mateus, D Lefeuvre, et al.
Cancer Chemotherapy and Pharmacology|May 31, 2021
Dabrafenib and trametinib exposure-efficacy and tolerance in metastatic melanoma patients: a pharmacokinetic-pharmacodynamic real-life studyLauriane Goldwirt, B Louveau, B Baroudjian, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2021
Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapyE Ghisoni, A Wicky, H Bouchaab, et al.
Pageof 1